Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Children Aged 1-12 Years

NCT06614816 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1200
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Southeast University, China

Collaborators